Abstract |
64 out-patients suffering from recurrent UTI were treated under double-blind conditions with one capsule daily of either the biological response modifier OM-8930 or the placebo for 3 months, followed by a 3-month observation period. Dysuria, bacteriuria, leucocyturia and antibiotic or chemotherapeutic consumption showed a significant reduction under OM-8930 in comparison with the placebo. As to the tolerance, a single case of allergic exanthema on the neck was observed in the OM-8930 group. Both the curative efficacy in the acute crisis and the consolidative efficacy in preventing further recurrences showed a highly significant superior effect of OM-8930 with respect to the placebo.
|
Authors | C Frey, W Obolensky, H Wyss |
Journal | Urologia internationalis
(Urol Int)
Vol. 41
Issue 6
Pg. 444-6
( 1986)
ISSN: 0042-1138 [Print] Switzerland |
PMID | 3547993
(Publication Type: Clinical Trial, Controlled Clinical Trial, Journal Article, Randomized Controlled Trial)
|
Chemical References |
|
Topics |
- Adjuvants, Immunologic
(therapeutic use)
- Adult
- Aged
- Aged, 80 and over
- Escherichia coli
(immunology)
- Female
- Humans
- Male
- Middle Aged
- Recurrence
- Urinary Tract Infections
(therapy)
|